Navigation Links
Pharmacyclics Reports Second Quarter 2013 Results
Date:7/31/2013

py.  The study will assess the safety and tolerability of ibrutinib as well as progression-free survival. This study is sponsored by the Dana-Farber Cancer Institute and completed enrollment of 63 patients.

MM

  • PCYC-1111: Phase II study of ibrutinib in patients with R/R multiple myeloma (MM). This is a Phase II, multi-center, open-label trial designed to assess the safety and efficacy of ibrutinib single agent and in combination with dexamethasone in patients with R/R MM. This study is conducted by Pharmacyclics and is currently exploring ibrutinib administration at 560 mg in combination with dexamethasone and 840 mg in combination with dexamethasone and 840 mg as a single agent. Pharmacyclics anticipates an update on this program will be provided during the first half of 2014.
  • Conference CallThe Company will hold a conference call today at 4:30 p.m. EDT. To participate in the conference call, please dial 1-877-303-7908 for domestic callers and 1-678-373-0875 for international callers. To access the live audio broadcast or the subsequent archived recording, log on to http://ir.pharmacyclics.com/events.cfm. To access a replay of the call please dial 1-855-859-2056 domestic callers and 1-404-537-3406 for international callers and use the conference ID number: 23863642.  The archived version of the webcast and conference call will be available for 30 days on the Investor Relations section of the Company's Web site at http://www.pharmacyclics.com.

    About IbrutinibIbrutinib is an investigational agent designed to provide potent and sustained inhibition of an enzyme called Bruton's tyrosine kinase (BTK). By inhibiting BTK, ibrutinib blocks B-cell receptor signaling. BTK is a key mediator of at least three critical B-cell pro-survival mechanisms occurring in parallel – regulation of apoptosis, adhesion, and cell migration and homing
    '/>"/>

    SOURCE Pharmacyclics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
    2. Pharmacyclics Reports First Quarter 2013 Results
    3. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
    4. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
    5. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
    6. Pharmacyclics, Inc. Prices Public Offering of Common Stock
    7. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
    8. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
    9. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
    10. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
    11. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/22/2014)... , Aug. 22, 2014  Cannabis Science, ... cannabis formulation-based drug development and related consulting, is ... third international medical cannabis conference taking place at ... France , on October 22, 2014.  The ... stakeholders, such as researchers, health professionals, and patients, ...
    (Date:8/22/2014)... TORONTO , Aug. 22, 2014 /PRNewswire/ - ... company that develops and commercializes proprietary technologies and ... it has entered into a Master Service Agreement ... their DNA-based pathogen detection assays. During the initial ... to deliver an automated working prototype of one ...
    (Date:8/21/2014)... Conn. , Aug. 21, 2014  Aptuit ... West Lafayette, Indiana , has enhanced ... and characterization of small and large molecules, including ... of the Bruker maXisPlus Q-TOF mass spectrometer. ... Goldman , CEO, Aptuit, said, "The expanded large ...
    Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2
    ... Aug. 19 On August 3, Macquarie University ... with its new Leksell Gamma Knife® Perfexion™ ... capable of providing dedicated intracranial radiosurgery. MUH and the ... Care, Australia,s leading provider of cancer management services, to ...
    ... EAU CLAIRE, Wis., Aug. 19 Leaders from healthcare, technology ... a day-long session in the Chippewa Valley technology corridor. Participants ... help overcome some of the biggest challenges facing the healthcare ... the summit which will be emceed by Dr. David Rhees, ...
    Cached Medicine Technology:Treatment with Elekta's Leksell Gamma Knife Perfexion Introduced to Cancer Patients in Australia 2Treatment with Elekta's Leksell Gamma Knife Perfexion Introduced to Cancer Patients in Australia 3Leaders to Discuss Future of Healthcare and Technology on Aug. 24 2Leaders to Discuss Future of Healthcare and Technology on Aug. 24 3
    (Date:8/23/2014)... MPWMD Board of Directors voted on Monday, August 18th to ... water for commercial and industrial properties. This was accomplished ... LLC in Carmel, California. , This is a historical ... in the State of California has approved this technology for ... time can now be used as a sole source of ...
    (Date:8/23/2014)... TX (PRWEB) August 23, 2014 Youth ... of Texas. It’s no different in Houston, TX. Substance ... are falling victim to drug and alcohol dependency in ... are looking to beat substance abuse, but don’t know ... juvenile treatment facility can be a challenge because most ...
    (Date:8/22/2014)... August 23, 2014 The IT manager ... reseller hosting for several years. He has recently announced ... best hosting suppliers in 2014. , GoDaddy is a ... rich features and great hosting solutions at affordable rates. ... price for shared hosting plans depend on the length ...
    (Date:8/22/2014)... Vegas, NV (PRWEB) August 22, 2014 ... email marketing services that currently helps more than ... efforts has caught the attention of Shane Michaels, prompting ... still a crucial element for any online marketing campaign, ... replacing email in the marketing world,” reports Michaels. “AWeber ...
    (Date:8/22/2014)... Sacramento, CA (PRWEB) August 22, 2014 Buying ... to an adult who is unsure about available coverage types ... now providing principal life insurance policy pricing to the public ... The use of this tool is free and is expected ... are available to the public throughout the U.S. The system ...
    Breaking Medicine News(10 mins):Health News:Historical Moment in the Monterey Peninsula, Brings Drought Relief Solution to California, with the Help of EcoloBlue and AWG Technology 2Health News:New Houston Hotline Assisting Juveniles in Locating Dependable Rehabilitation Help 2Health News:AWeber: Review Exposes Affordable Provider of Opt-In Email Marketing Services 2Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2
    ... Source Endurance is pleased to,announce that it ... Sports and,Fitness of San Marcos Texas to collaborate ... encompass several areas of,collaboration including the sharing and ... training approaches, and deployment of one,of the first ...
    ... 10 with serious trauma live, often with little visible damage, ... five years of war in Iraq, there,s some relatively ... 90 percent are now surviving injuries that would have been ... of The Journal of Craniofacial Surgery , the surgical ...
    ... WASHINGTON, March 24 The following is a,statement ... the Supreme,Court decision today declining AARP,s request to ... eliminate health benefits for retirees when,they reach 65 ... the Equal,Employment Opportunity Commission (EEOC) finalized and published ...
    ... Psoriasis patients urged to discuss risk factors with ... It has long been known that,psoriasis, a chronic ... itch and bleed, can have a significant negative ... dermatologists are finding that,psoriasis, especially severe psoriasis, is ...
    ... Could Change The Outcome Of This ... Year,s Presidential Election, MIAMI, March 24 With ... Hillary Clinton and,Barack Obama,s stress levels are at an all time high. ... city making,numerous public appearances. This can cause lack of sleep and lack ...
    ... OTTAWA, March 24 Natural,Nutrition, Inc. (OTC Bulletin ... subsidiary, CSI Business Finance, Inc., has been,renamed i-Nutrition, ... third,quarter 10Q, the lending activities of CSI Business ... been made, and all proceeds from loan payments,received ...
    Cached Medicine News:Health News:Source Endurance and So High Sports Announce Research Alliance for Physiology and Human Performance 2Health News:Source Endurance and So High Sports Announce Research Alliance for Physiology and Human Performance 3Health News:Innovative Care Is Helping Iraq War's Injured Survive 2Health News:Innovative Care Is Helping Iraq War's Injured Survive 3Health News:AARP 'Deeply Disappointed' by Supreme Court Decision on Retiree Health Care Benefits 2Health News:Research Shows Patients With Psoriasis at Increased Risk for Developing Other Serious Medical Conditions 2Health News:Research Shows Patients With Psoriasis at Increased Risk for Developing Other Serious Medical Conditions 3Health News:Research Shows Patients With Psoriasis at Increased Risk for Developing Other Serious Medical Conditions 4Health News:Stress On The Campaign Trail, One Issue All The Candidates Agree On 2Health News:Natural Nutrition Renames Former Business Lending Subsidiary i-Nutrition, Inc. 2
    Adsons bayonet forceps....
    ... designed to accept rigid fixation ... an excellent reconstructive option for ... blowout defects. Each design has ... one or more rigid fixation ...
    ... Rim is designed to augment ... the midface, including the inferior ... positioned in the hollow under ... Rim implant aids in restoring ...
    Flattened points in vertical plane, straight shafts, cross action, round handle....
    Medicine Products: